Dr. Reddy’s Laboratories Ltd.

In News

Dr. Reddy's Laboratories slides Friday, still outperforms market - MarketWatch

MarketWatch - Aug 07, 2026

Arrowstreet Capital Limited Partnership Buys Shares of 102,643 Dr. Reddy's Laboratories Ltd $RDY - MarketBeat

MarketBeat - Aug 06, 2026

Dr Reddy's Laboratories Ltd (RDY) Q1 2027 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance

Yahoo Finance - Jul 27, 2026

Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States - Business Wire

Business Wire - Aug 04, 2026

Dr. Reddy’s Laboratories (NYSE: RDY) secures FDA approval for rituximab biosimilar - Stock Titan

Stock Titan - Aug 03, 2026

Indian drugmaker Dr Reddy's slips on margin, semaglutide supply woes - Reuters

Reuters - Jul 23, 2026

Dr Reddy's Terminates Novartis India Agreement After Ownership Change - NDTV Profit

NDTV Profit - Aug 08, 2026

Dr. Reddy's Laboratories Ltd (RDY): Investor Outlook Reveals 14% Potential Upside In Healthcare Sector - DirectorsTalk Interviews

DirectorsTalk Interviews - Aug 03, 2026

Dr. Reddy's Q4 & Full Year FY26 Financial Results - SEC.gov - sec.gov

sec.gov - May 12, 2026

Dr. Reddy's Laboratories Ltd $RDY Shares Purchased by Quantinno Capital Management LP - MarketBeat

MarketBeat - Aug 05, 2026

Dr. Reddy's Q1 Earnings and Revenues Miss Estimates, Stock Down - Yahoo Finance

Yahoo Finance - Jul 23, 2026

FDA issues Form 483 after Dr. Reddy’s (NYSE: RDY) plant inspection - Stock Titan

Stock Titan - Jul 29, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment